Riew K Daniel, Long John, Rhee John, Lewis Stephen, Kuklo Timothy, Kim Yong Jung, Yukawa Yasutsugu, Zhu Yong
Department of Orthopaedic Surgery, Barnes-Jewish Hospital at Washington University, St. Louis, Missouri 63110, USA.
J Bone Joint Surg Am. 2003 Apr;85(4):632-4. doi: 10.2106/00004623-200304000-00007.
The use of nonsteroidal anti-inflammatory drugs following spine arthrodesis is discouraged because of the negative effects on bone-healing. We are not aware of any data regarding when nonsteroidal anti-inflammatory drugs may be safely resumed postoperatively. We hypothesized that these drugs have a time-dependent deleterious effect on fusion, with the greatest inhibition during the early phases of fusion.
Seventy New Zealand White rabbits underwent posterior intertransverse process arthrodesis at L5-L6 with use of iliac autograft. Rabbits randomly received indomethacin (10 mg/kg orally) starting at two weeks after surgery (twenty-four animals), indomethacin starting at four weeks postoperatively (twenty-three), or saline starting at two weeks postoperatively (twenty-three) (the control group). The animals were killed at six weeks, and the spines were denuded of soft tissues and palpated for L5-L6 motion. Fusion was defined as the complete absence of motion.
Sixty-five percent (fifteen) of the twenty-three spines in the control group and 48% (eleven) of the twenty-three in the four-week group fused. However, only 21% (five) of the twenty-four spines in the two-week group fused. The difference between the two-week and control groups was significant (p < 0.002), as was the difference between the two and four-week groups (p = 0.05). The difference between the four-week and control groups was not significant (p = 0.2).
The earlier that indomethacin was resumed postoperatively, the greater was its negative effect on fusion. Indomethacin appears to play a significant inhibitory role in the early phase of healing. Initiating indomethacin treatment in the latter phase of healing does not appear to significantly affect fusion rates, although there was a nonsignificant trend toward inhibition. To our knowledge, this is the first investigation of the time-dependent nature of indomethacin's effect on bone-healing.
由于对骨愈合有负面影响,脊柱融合术后不鼓励使用非甾体抗炎药。我们并不知晓关于术后何时可以安全恢复使用非甾体抗炎药的任何数据。我们推测这些药物对融合具有时间依赖性的有害影响,在融合早期抑制作用最大。
70只新西兰白兔在L5-L6节段行后外侧横突间融合术并使用自体髂骨移植。兔子随机分组,术后两周开始口服吲哚美辛(10mg/kg)(24只动物),术后四周开始口服吲哚美辛(23只),或术后两周开始给予生理盐水(23只)(对照组)。六周时处死动物,去除脊柱软组织并触诊L5-L6节段的活动情况。融合定义为完全无活动。
对照组23个脊柱中有65%(15个)融合,四周组23个中有48%(11个)融合。然而,两周组24个脊柱中只有21%(5个)融合。两周组与对照组之间的差异具有显著性(p<0.002),两周组与四周组之间的差异也具有显著性(p = 0.05)。四周组与对照组之间的差异无显著性(p = 0.2)。
术后恢复使用吲哚美辛的时间越早,其对融合的负面影响越大。吲哚美辛在愈合早期似乎发挥了显著的抑制作用。在愈合后期开始使用吲哚美辛治疗似乎不会显著影响融合率,尽管有不显著的抑制趋势。据我们所知,这是首次对吲哚美辛对骨愈合影响的时间依赖性进行的研究。